Letter to the EditorRe: Matthias Oelke, François Giuliano, Vincenzo Mirone, et al., Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial. Eur Urol 2012;61:917–25
Section snippets
Conflicts of interest
The authors have nothing to disclose.
References (8)
- et al.
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial
Eur Urol
(2012) - et al.
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia
Eur Urol
(2011) - et al.
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
Eur Urol
(2008) - et al.
Phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis
Urology
(2011)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.